Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rook

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 23, 2014
Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profilesJerri M Rook, Mohammed N Tantawy, Mohammad S Ansari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2011
Donor kidney adapts to body dimensions of recipient: no influence of donor gender on renal function after transplantationH Tent, A T Lely, T J Toering, et al.
JCI Insight|January 21, 2021
A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypesNicole M Fisher, Aqeela AlHashim, Aditi B Buch, et al.
BMC Public Health|March 20, 2025
Interpersonal violence-related physical injury in low- and middle-income countries and its association with markers of socioeconomic status: a systematic reviewKevin J Blair, Haley Tupper, Jordan M Rook, et al.
Neuron|December 22, 2017
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M<sub>4</sub> Muscarinic ReceptorMark S Moehle, Tristano Pancani, Nellie Byun, et al.
Human Molecular Genetics|March 4, 2016
mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Jerri M Rook, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Neuron|September 13, 2016
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine ReleaseDaniel J Foster, Jermaine M Wilson, Daniel H Remke, et al.
Molecular Pharmacology|August 7, 2012
Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationshipsKaren J Gregory, Meredith J Noetzel, Jerri M Rook, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 23, 2014
Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profilesJerri M Rook, Mohammed N Tantawy, Mohammad S Ansari, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2011
Donor kidney adapts to body dimensions of recipient: no influence of donor gender on renal function after transplantationH Tent, A T Lely, T J Toering, et al.
JCI Insight|January 21, 2021
A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypesNicole M Fisher, Aqeela AlHashim, Aditi B Buch, et al.
BMC Public Health|March 20, 2025
Interpersonal violence-related physical injury in low- and middle-income countries and its association with markers of socioeconomic status: a systematic reviewKevin J Blair, Haley Tupper, Jordan M Rook, et al.
Neuron|December 22, 2017
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M<sub>4</sub> Muscarinic ReceptorMark S Moehle, Tristano Pancani, Nellie Byun, et al.
Human Molecular Genetics|March 4, 2016
mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Jerri M Rook, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Neuron|September 13, 2016
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine ReleaseDaniel J Foster, Jermaine M Wilson, Daniel H Remke, et al.
Molecular Pharmacology|August 7, 2012
Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationshipsKaren J Gregory, Meredith J Noetzel, Jerri M Rook, et al.
Pageof 11